Alternatives to Developmental Genotype-Tissue Expression Project
Developmental Genotype-Tissue Expression Project is a Biotechnology tool: establishing the first comprehensive database of healthy pediatric tissue gene expression to understand genetic influences on childhood development and diseases. Here are the 48 closest alternatives, compared on pricing, features and what real users say.
The 20 closest Biotechnology companies to Developmental Genotype-Tissue Expression Project
VizgenNot ratedSpatial multiomics company developing technologies for single-cell gene expression profiling in intact tissues.
Network BioNot ratedLeveraging AI and a massive patient tissue dataset to accelerate drug discovery and advance precision medicine.
InfinimmuneNot ratedDeveloping human-derived antibodies for inflammatory diseases and cancer using AI and proprietary platforms.
IMU BiosciencesNot ratedDecoding the immune system to pioneer a paradigm shift in disease diagnosis and treatment.
ExobiosphereNot ratedSpace BioTech startup developing an autonomous, high-throughput screening platform for drug discovery in microgravity.
Moderna2.0 out of 5 (1)Moderna is a biotechnology company pioneering mRNA medicine, best known for its COVID-19 vaccine and a broad pipeline of mRNA-based therapeutics.
Mammoth BiosciencesNot ratedBiotechnology company leveraging ultracompact CRISPR systems for gene editing therapies and diagnostics.
Epicrispr BiotechnologiesNot ratedEpicrispr Biotechnologies is a biotechnology company developing novel epigenetic therapies, with a lead program targeting Facioscapulohumeral Muscular Dystrophy (FSHD).
Pixelgen TechnologiesNot ratedA life sciences company that has developed a high-throughput platform for mapping molecular cell architecture at nanoscale resolution.
LifeMine Therapeutics Inc.Not ratedClinical-stage biopharmaceutical company leveraging a proprietary platform to discover and develop novel precision medicines from fungi.
QuartzyNot ratedA vertically-integrated procurement platform for the life sciences industry.
FreenomeNot ratedFreenome is a biotechnology company developing a multi-cancer early detection blood test using machine learning and biology.
MironidNot ratedBiopharmaceutical company developing novel small-molecule therapeutics for rare kidney diseases, particularly Autosomal Dominant Polycystic Kidney Disease (ADPKD).
Spark TherapeuticsNot ratedA biotechnology company developing gene therapy treatments for rare, debilitating genetic diseases.
Adaptyv BiosystemsNot ratedAutomated wet lab for AI-driven protein design, enabling rapid synthesis, expression, and testing of thousands of protein designs.
- EAEarendil LabsNot rated
Earendil Labs is an AI biotechnology company focused on leveraging artificial intelligence for drug discovery and development of next-generation biologics.
Arc InstituteNot ratedA nonprofit research organization leveraging AI and biotechnology to understand and treat complex diseases.
Transcripta BioNot ratedAI-powered drug discovery company focused on neurological and neuromuscular diseases, leveraging transcriptomics to accelerate therapeutic development.
Element BiosciencesNot ratedRevolutionizing genomic analysis with innovative sequencing technology.
Waypoint BioNot ratedAI-native biotech company designing next-generation CAR T therapies for solid tumors.
Showing the next 20 closest matches. See the rest on the Developmental Genotype-Tissue Expression Project profile.
Sponsored rows are paid and labelled. Advertise on this page
